In the same way, Di Filippo et al. [25] also identified leptin as a promising diagnostic biomarker of GDM assessed against the oral glucose tolerance test (OGTT) from the second trimester to birth with a sensitivity and specificity >90% in adequate sample sizes (≥ 100). This evidence concerns the gene LEP and gestational diabetes.